Kennametal (KMT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Sep, 2026Executive summary
Annual shareholder meeting scheduled for October 27, 2026, to be held virtually; shareholders will vote on director elections, auditor ratification, and executive compensation approval.
Joseph Alvarado will become Chairman of the Board, succeeding William Lambert, reflecting planned board leadership succession.
Fiscal 2026 saw strong financial performance: sales rose to $2.4 billion, net income reached $342.4 million, and adjusted EBITDA margin improved to 26.9%.
Return on Invested Capital (ROIC) increased to 18.8% (adjusted), up from 6.8% in the prior year.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors for one-year terms, ratification of PricewaterhouseCoopers LLP as independent auditor for FY2027, and a non-binding advisory vote on executive compensation.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2027 meeting must be submitted between May 1 and June 30, 2027.
Board of directors and corporate governance
Board is declassified; all directors serve one-year terms.
CEO and Chairman roles are separated; Chairman is an independent director.
Board comprises all independent directors except the CEO.
Three standing committees: Audit, Compensation and Human Capital, and Nominating/Corporate Governance, all composed of independent directors.
Annual board and committee self-evaluations are conducted.
Stock ownership guidelines require directors to hold equity worth at least five times the annual retainer.
No poison pill is in place.
Latest events from Kennametal
- Record FY26 sales and margins set up for continued growth and strong FY27 outlook.KMT
Q4 2026 - Q3 sales and margins surged on price, volume, and tungsten dynamics; FY26 outlook raised.KMT
Q3 2026 - Q2 sales and margins surged, prompting raised full-year guidance and continued strong outlook.KMT
Q2 2026 - Annual meeting to vote on directors, auditor, executive pay, and new incentive plan.KMT
Proxy Filing - Board recommends approval of all 2025 proxy proposals, emphasizing pay-for-performance and ESG.KMT
Proxy Filing - Sales and margins declined, but cash flow and shareholder returns improved.KMT
Q1 2025 - Q4 delivered margin gains and strong cash flow; FY25 outlook signals stable, cautious growth.KMT
Q4 2024 - Adjusted EPS rose to $0.47 despite a 6% sales decline, aided by credits and cost actions.KMT
Q3 2025 - Sales and earnings declined, but margin and cash flow gains reflect cost actions and restructuring.KMT
Q2 2025